The immunogenetics of bone marrow transplantation.
It is now clear that it is not necessary to use an HLA genotypically identical donor to have a successful marrow transplant. However, it is equally clear that the likelihood of complications increases with each increment in histoincompatibility. The implication is that histocompatibility testing must be of the highest possible precision to choose the optimal donor, and to predict the risk of adverse alloreactivity. Most clinicians would seriously consider transplantation from a one locus-mismatched relative or an HLA-matched unrelated donor in virtually any situation in which transplantation from a matched sibling would be felt to be the standard of care. More thought would need to go into transplantation from a two or three locus-mismatched relative or a mismatched unrelated donor.
Beatty
P G
PG
Bone Marrow Transplant Program, University of Utah Health Sciences Center, Salt Lake City 84132.
D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000276:immunology*; D006084:Graft Rejection; D006086:Graft vs Host Disease / Q000209:etiology / Q000235:genetics / Q000276:immunology / Q000517:prevention & control; D006680:HLA Antigens / Q000145:classification / Q000235:genetics / Q000276:immunology; D006650:Histocompatibility Testing; D006801:Humans; D011110:Polymorphism, Genetic; D014019:Tissue Donors / Q000706:statistics & numerical data; D009927:Tissue and Organ Procurement / Q000706:statistics & numerical data
D006680:HLA Antigens